Developing a case study model for successful translation of stem cell therapies

Alan Trounson; Elona Baum; Don Gibbons; Patricia Tekamp-Olson

doi:10.1016/j.stem.2010.05.008

Developing a case study model for successful translation of stem cell therapies

Cell Stem Cell. 2010 Jun 4;6(6):513-6. doi: 10.1016/j.stem.2010.05.008.

Authors

Alan Trounson¹, Elona Baum, Don Gibbons, Patricia Tekamp-Olson

Affiliation

¹ California Institute for Regenerative Medicine, San Francisco, CA 94107, USA. atrounson@cirm.ca.gov

PMID: 20569687
DOI: 10.1016/j.stem.2010.05.008

Abstract

Cell therapies derived from pluripotent stem cells are entering the preclinical and early clinical development phase, but eventual translation faces many challenges. We describe a new approach by California to form global public-private "disease team" partnerships to enable new clinical opportunities to be evaluated in the complex regulatory environment.

MeSH terms

California
Cell- and Tissue-Based Therapy* / economics
Clinical Trials as Topic*
Humans
Insurance, Health
Legislation, Medical
Models, Econometric*
Organizational Case Studies
Pluripotent Stem Cells*
Public-Private Sector Partnerships
Research Support as Topic*
Translational Research, Biomedical